Leistritz has added a continuous twin screw extrusion system that continuously mixes and conditions gel-mass formulations designed to replace previous upstream batch processing methodologies.
Leistritz has added a continuous twin screw extrusion system that continuously mixes and conditions gel-mass formulations designed to replace previous upstream batch processing methodologies.
The LS model twin screw extruder features a modular process section manufactured from stainless steel or other suitable metallurgies. Screw diameters range from 12–260 mm. Controls include feed rates, screw rpms, temperatures, and vacuum level. Readouts include product temperature, discharge pressure, and optical sensors. Screws are assembled on high-torque shafts, and shear and energy are imparted into the materials being processed via rotating screws. Each barrel section uses electric heaters and liquid cooling via internal cooling bores. Barrels can be interfaced to liquid temperature control units for process section temperature setpoints, eliminating the cartridge heaters. The system is available for process development and testing at the company’s process laboratory in Somerville, NJ.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.